首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Coronary Artery Bypass Grafting Using the Radial Artery Clinical Outcomes., Patency, and Need for Reintervention
【24h】

Coronary Artery Bypass Grafting Using the Radial Artery Clinical Outcomes., Patency, and Need for Reintervention

机译:使用the动脉的临床结果,通畅性和需要再次干预的冠状动脉旁路移植术

获取原文
获取原文并翻译 | 示例
           

摘要

Background-Radial artery (RA) grafts are an attractive second arterial conduit after the left internal thoracic artery (LITA) for coronary artery bypass graft (CABG) surgery. However, long-term outcomes and the need for subsequent reintervention have not been defined.Methods and Results-We performed a retrospective cohort study of our single institution's 16-year experience with 1851 consecutive patients (average age, 58 years; 82% men, 36% diabetic) undergoing primary, isolated CABG with the LITA, RA, and saphenous vein as needed. Average grafts per patient were 3.8, with 2.4 arterial grafts per patient. Survival was determined using the Social Security Death Index. Grafts were nonpatent if they had a >50% stenosis, a string sign, or were occluded. Five patients (0.3%) died in hospital and 0.8% had a myocardial infarction, 1.1% a stroke, and 0.6% renal failure. Kaplan-Meier-estimated 1-, 5-, 10-, and 15-year survival was 99%, 96%, 89%, and 75%, respectively. Of the cohort, 278 symptomatic patients underwent cardiac catheterization at our institution an average of 5.0+-3.8 years (range, 0.1-12 years) after CABG. Overall RA (n=420 grafts) patency was 82% and SV (n=364 grafts) patency, 47% CP<0.0001). LITA (n=287 grafts including 9 sequential grafts) patency was 85% and right internal thoracic artery (n=15 grafts) patency was 80% (P=0.6). RA patency was not different from LITA patency (P=0.3). Overall freedom from catheterization, percutaneous coronary intervention, and CABG was 85%, 97%, and 99%, respectively.Conclusions-RA grafting is a highly effective revascularization strategy providing excellent short and long-term outcomes with very low rates of reintervention. RA patency is similar to LITA patency and is much better than SV patency. RA grafting should be more widely utilized in patients undergoing CABG.
机译:背景-Radi动脉(RA)移植物是左胸内动脉(LITA)之后用于冠状动脉搭桥术(CABG)手术的有吸引力的第二条动脉导管。然而,长期结果和后续干预的需求尚未确定。方法和结果-我们对单一机构16年的经验进行了回顾性队列研究,连续1851名患者(平均年龄58岁; 82%的男性, 36%的糖尿病患者)根据需要接受LITA,RA和隐静脉的原发性孤立CABG治疗。每位患者的平均移植物为3.8,每位患者为2.4动脉移植物。使用社会保障死亡指数确定存活率。如果移植物的狭窄程度> 50%,弦状迹象或被阻塞,则为非专利。 5名患者(0.3%)在医院死亡,0.8%的患者患有心肌梗死,中风为1.1%,肾衰竭为0.6%。 Kaplan-Meier估计的1年,5年,10年和15年生存率分别为99%,96%,89%和75%。在该队列中,有278名有症状的患者在CABG后平均经过5.0 + -3.8年(0.1-12年)的时间接受了心脏导管检查。总的RA(n = 420移植物)通畅率为82%,而SV(n = 364移植物)通畅,47%CP <0.0001)。 LITA(n = 287个移植物,包括9个连续移植物)通畅率为85%,右胸内动脉(n = 15个移植物)通畅率为80%(P = 0.6)。 RA通畅与LITA通畅没有差异(P = 0.3)。插管,经皮冠状动脉介入治疗和CABG的总体自由度分别为85%,97%和99%。结论-RA移植是一种高效的血运重建策略,可提供极好的短期和长期预后,再干预率极低。 RA通畅与LITA通畅相似,并且比SV通畅好得多。 RA移植应在接受CABG的患者中更广泛地使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号